Read your latest personalised notifications
Log in
No account yet? Start here
Don't miss out
Ok, got it
Review slides, abstracts, videos and interviews from previous editions of ESC Congress in one online library
News and opinion on the latest ESC Clinical Practice Guidelines
1. Preamble2. Introduction.3. Epidemiology and risk factors 3.1 Epidemiology 3.2 Risk factors 3.3 Prognosis4.General aspects 4.1.Diagnostic approach 4.2 Treatment approach5.Antithrombotic drugs in PADs 5.1 Antithrombotic treatment in carotid artery disease 5.2 Antithrombotic therapy in lower extremity artery disease. 5.3 Antithrombotic therapy in lower extremity artery disease patients requiring long-term oral anticoagulant 5.4 Antithrombotic therapy after endovascular therapy in other territories6. Extracranial carotid and vertebral artery disease 6.1 Carotid artery disease 6.2 Vertebral artery disease7.Upper extremity artery disease. 7.4Diagnosticmethods 7.5 Treatment8.Mesenteric artery disease 8.1 Acute mesenteric ischaemia 8.2 Chronicmesenteric artery disease9.Renal artery disease 9.1 Introduction 9.2 Clinical presentation 9.3 Natural history 9.4 Diagnostic strategy 9.5 Prognosis 9.6 Treatment10. Lower extremity artery disease 10.1. Clinical presentation and natural history 10.2 Diagnostic tests 10.3 Medical treatment 10.4 Revascularization options: general aspects 10.5 Management of intermittent claudication 10.6 Chronic limb-threatening ischaemia 10.7Acute limb ischaemia 10.8 Blue toe syndrome11. Multisite artery disease 11.1 Multisite artery disease: epidemiology and impact prognosis. 11.2 Screening for and management of multisite artery disease12. Cardiac conditions in peripheral arterial diseases 12.1 Introduction 12.2 Heart failure and peripheral arterial diseases 12.3 Peripheral arterial diseases and atrial fibrillation 12.4 Peripheral arterial diseases and valvular heart disease 12.5 Peripheral arterial diseases and vascular access site for cardiac interventions13. Gaps in evidence14. To do and not to do messages from the Guidelines15.Web addenda and companion document16. Appendix17. References
Our mission: To reduce the burden of cardiovascular disease
